Characterizations of the β-amyloid (Aβ)-membrane interaction intermediates

Area of Science:

• Biochemistry
• Neuroscience
• Biophysics

Background:

• Alzheimer's disease (AD) pathogenesis is linked to amyloidogenic aggregation of β-amyloid (Aβ) peptides.
• Aβ-induced non-specific membrane disruption is a key molecular mechanism in AD.
• Understanding Aβ-membrane intermediate states is vital for elucidating AD's molecular basis.

Purpose of the Study:

• To review experimental and data analysis protocols for characterizing Aβ-membrane intermediate states.
• To address challenges posed by the heterogeneous, low-abundant, and insoluble nature of these intermediates.
• To enhance the biological relevance of structural characterizations through combined methodologies.

Main Methods:

• Solid-state nuclear magnetic resonance (ssNMR) spectroscopy as the primary technique.
• Application of quantitative and sensitivity-enhanced ssNMR approaches.
• Integration with membrane biophysical and/or cell-based biophysical assays.

Main Results:

• Established protocols for ssNMR-based structural and dynamic characterization of Aβ-membrane systems.
• Demonstrated feasibility of studying challenging heterogeneous and low-abundant intermediate states.
• Provided a framework for maximizing biological relevance in structural studies.

Conclusions:

• Solid-state NMR is a powerful tool for investigating Aβ-membrane interactions in Alzheimer's disease.
• Combining ssNMR with biophysical assays enhances the study of Aβ aggregation intermediates.
• Methodological advancements are critical for understanding the molecular underpinnings of AD pathology.